Medical Advancement

Israel Aiming to Enable Unprecedented Human DNA Edits, to Help Cure Illnesses

Friday, June 5, 2020

Israel is setting up a task force aimed at bringing a new level of accuracy to genome editing, in the hope it will pave the way to cures for various medical conditions. The state-run Israel Innovation Authority (IIA) has allocated NIS 36 million ($10 million) for the country’s academic institutions and several companies to advance … Read More

6 Coronavirus Vaccine Developments From Israel to Watch

Thursday, May 28, 2020

Research groups across the world are using a variety of approaches to formulating vaccines that could protect people from coronavirus SARS-CoV-2 (Covid-19). Big money and urgent demand are accelerating the normally lengthy process of vaccine development (see our companion story, “In the race for a coronavirus vaccine, first doesn’t mean best,” to read what two … Read More

Three Gulf States Reach Out to Israel for Help Battling COVID-19 Pandemic

Monday, May 11, 2020

Three states in the Arab Gulf are actively engaged in cooperation with Israel’s health system, with one having recently asked for help installing an advanced telemedicine system to confront the coronavirus pandemic, a senior official at one of the country’s leading hospitals said Sunday. Top representatives from Bahrain and the United Arab Emirates have been … Read More

Israel’s IIBR Completes Development Phase of COVID-19 Antibody

Tuesday, May 5, 2020

The Israel Institute for Biological Research (IIBR) has completed the development phase of COVID-19 antibody or passive vaccine, according to a statement by the Defense Ministry.  Defense Minister Naftali Bennett visited the Ness Ziona-based lab on Monday and was briefed by the research team, who revealed a breakthrough antibody that attacks the virus and neutralizes … Read More

Israeli Developers of Corona Vaccine to Initiate Human Clinical Trials in Summer

Monday, April 27, 2020

An Israeli company working on a COVID-19 vaccine will begin human trials this summer, a senior company official said on Wednesday. MigVax, an affiliate of the Migal Galilee Research Institute, will conduct safety and efficacy assessment in rodents starting next month. Phase 1 of clinical trials in humans will start during the summer and last … Read More

OurCrowd to Back Israeli COVID-19 Vaccine Company in $12 Million Round

Friday, April 24, 2020

Jerusalem-based equity crowdfunding company OurCrowd will lead a $12 million investment round for newly formed Covid-19 vaccine company MigVax, the company announced in a statement on Wednesday. MigVax intends to use the funds to accelerate the development of a coronavirus vaccine and bring it to the market. “We are humbled by the opportunity to invest … Read More

Tel Aviv University Professor Granted US Patent for Coronavirus Vaccine Design

Tuesday, April 21, 2020

A professor at Tel Aviv University (TAU) has been granted a patent by the United States Patent and Trademark Office (USPTO) for his innovative vaccine design for the novel coronavirus, also known as SARS-CoV-2, TAU announced on Sunday. Prof. Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology at TAU’s George S. Wise Faculty … Read More

US Patient Receives Israeli Coronavirus Treatment with 100 Percent Survival Rate

Friday, April 17, 2020

An American patient diagnosed with the coronavirus (COVID-19) has been given a treatment by Israeli-based Pluristem that, so far, has a 100 percent survival rate. The development, which occurred under the Israel’s compassionate-use program, comes days after the company released preliminary data showing that six critically ill coronavirus patients in the Jewish state who are … Read More